Racial variation in clinical and immunological manifestations of systemic sclerosis

被引:0
|
作者
Nietert, PJ
Mitchell, HC
Bolster, MB
Shaftman, SR
Tilley, BC
Silver, RM
机构
[1] Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Charleston, SC USA
[2] Med Univ S Carolina, Dept Med, Charleston, SC USA
[3] Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC USA
关键词
scleroderma; continental population groups; racial disparities; autoantibodies; demographics; clinical manifestations;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To clarify which racial differences in disease manifestations can be attributed to differences in other factors such as gender, education, disease classification, and disease duration. Methods. The study included white and black patients with systemic sclerosis (SSc) treated at a university hospital rheumatology clinic between November 1997 and April 2003. Demographic, clinical, and immunological measurements were obtained on each subject. Using multivariable statistical techniques we assessed differences in disease manifestations between white and black patients after adjusting for gender and classification and duration of disease. Results. Two hundred sixty-three patients (199 whites, 64 blacks) were enrolled in the study. Blacks experienced an earlier age at disease onset than whites and were significantly more likely to have diffuse disease, digital ulcers, digital pitting, impaired lung function, and anti-RNP, and anti-Ro antibodies. Whites were significantly more likely to have anti-centromere antibodies. Conclusion. After adjusting for gender, disease classification, and disease duration, whites and blacks with SSc differ in some clinical and immunological manifestations of disease. Whether these differences can be attributed to genetic or environmental factors remains unknown.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 50 条
  • [41] Esophagus involvement in systemic sclerosis: ultrasound parameters and association with clinical manifestations
    Li Ma
    Qingli Zhu
    Yan Zhang
    Jianchu Li
    Yuxin Jiang
    Dong Xu
    Xiaofeng Zeng
    Yong Hou
    He Liu
    Arthritis Research & Therapy, 23
  • [42] Systemic sclerosis manifestations and clinical outcomes in Hispanics/Latinos of the American Southwest
    Nunez, Sharon E.
    Ariza-Hutchinson, Angie
    Fields, Roderick A.
    Vondenberg, Jaime A.
    Patel, Rosemina A.
    Emil, N. Suzanne
    Muruganandam, Maheswari
    Gibb, James, I
    Poole, Janet L.
    Sibbitt, Wilmer L., Jr.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2022, 7 (02) : 135 - 143
  • [43] Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans
    Tager, RE
    Tikly, M
    RHEUMATOLOGY, 1999, 38 (05) : 397 - 400
  • [44] Esophagus involvement in systemic sclerosis: ultrasound parameters and association with clinical manifestations
    Ma, Li
    Zhu, Qingli
    Zhang, Yan
    Li, Jianchu
    Jiang, Yuxin
    Xu, Dong
    Zeng, Xiaofeng
    Hou, Yong
    Liu, He
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [45] Investigation of echocardiographic manifestations in 100 patients with systemic sclerosis and its relationship with severity of clinical manifestations
    Mowla, K.
    Saraj, M.
    Saeidian, M.
    Kojoury, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 217 - 217
  • [46] CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS - IDENTIFICATION OF RACIAL AND SOCIOECONOMIC INFLUENCES
    WARD, MM
    STUDENSKI, S
    ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (04) : 849 - 853
  • [47] CLINICAL AND IMMUNOLOGICAL PARALLELS IN SYSTEMIC-SCLEROSIS AND RHEUMATOID-ARTHRITIS
    GONTAR, IP
    CHERNOVA, SI
    RAZA, MY
    ZBOROVSKY, AB
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 183 - 183
  • [48] CYCLOSPORINE IN TREATMENT OF PROGRESSIVE SYSTEMIC-SCLEROSIS - CLINICAL AND IMMUNOLOGICAL FINDINGS
    IPPOLITI, G
    MIORI, L
    NEGRI, M
    ROVATI, B
    LORENZUTTI, F
    ZERBINATI, N
    RABBIOSI, G
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (06) : 3117 - 3118
  • [49] Systemic therapy with calcitonin has positive clinical effects on systemic sclerosis in patients with cutaneous manifestations
    Uslu, Ugur
    Streiff, Laura
    Sticherling, Michael
    EUROPEAN JOURNAL OF DERMATOLOGY, 2018, 28 (03) : 364 - 369
  • [50] Systemic therapy with calcitonin has positive clinical effects on systemic sclerosis in patients with cutaneous manifestations
    Ugur Uslu
    Laura Streiff
    Michael Sticherling
    European Journal of Dermatology, 2018, 28 : 364 - 369